Free Trial
NASDAQ:XCUR

Exicure (XCUR) Stock Price, News & Analysis

Exicure logo
$9.77 +0.05 (+0.51%)
Closing price 05/30/2025 04:00 PM Eastern
Extended Trading
$9.94 +0.17 (+1.69%)
As of 05/30/2025 07:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Exicure Stock (NASDAQ:XCUR)

Key Stats

Today's Range
$9.54
$10.00
50-Day Range
$8.44
$14.00
52-Week Range
$1.44
$36.00
Volume
3,138 shs
Average Volume
567,148 shs
Market Capitalization
$61.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Exicure, Inc., an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.

Exicure Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
22nd Percentile Overall Score

XCUR MarketRank™: 

Exicure scored higher than 22% of companies evaluated by MarketBeat, and ranked 858th out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Exicure.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Exicure is -4.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Exicure is -4.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Exicure has a P/B Ratio of 5.58. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Exicure's valuation and earnings.
  • Percentage of Shares Shorted

    1.30% of the float of Exicure has been sold short.
  • Short Interest Ratio / Days to Cover

    Exicure has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Exicure has recently increased by 13.27%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Exicure does not currently pay a dividend.

  • Dividend Growth

    Exicure does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.30% of the float of Exicure has been sold short.
  • Short Interest Ratio / Days to Cover

    Exicure has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Exicure has recently increased by 13.27%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Exicure has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Exicure this week, compared to 1 article on an average week.
  • Search Interest

    Only 1 people have searched for XCUR on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Exicure insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.90% of the stock of Exicure is held by insiders.

  • Percentage Held by Institutions

    42.82% of the stock of Exicure is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Exicure's insider trading history.
Receive XCUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exicure and its competitors with MarketBeat's FREE daily newsletter.

XCUR Stock News Headlines

This document could hand you a shot at $915 every single weekend!
Something fascinating happens in the options market when most traders aren't paying attention… While everyone else collects standard daily premiums Monday through Friday... There's a special opportunity to target TRIPLE premiums just for holding positions over the weekend. Think about that... Most traders get one day's worth of premium for their trades. But by entering right before the weekend, when everything works out, you could collect THREE days worth - even though markets are closed for two of them. Thanks to a special discovery by a Wall Street legend who helped manage a $1.7 trillion firm – regular folks like you can now target extra cash from the markets on weekends… Just like he showed his small group of traders on December 20th with KO... A quick 2-minute setup Friday afternoon… Head out for the weekend... Monday morning? An extra $1,111 sitting in the account (with a $5k starting stake).
See More Headlines

XCUR Stock Analysis - Frequently Asked Questions

Exicure's stock was trading at $13.67 at the beginning of 2025. Since then, XCUR stock has decreased by 28.5% and is now trading at $9.77.
View the best growth stocks for 2025 here
.

Exicure, Inc. (NASDAQ:XCUR) announced its quarterly earnings results on Tuesday, March, 18th. The company reported ($3.39) earnings per share (EPS) for the quarter.

Exicure shares reverse split on Tuesday, August 27th 2024. The 1-5 reverse split was announced on Monday, August 26th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 26th 2024. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Shares of XCUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Exicure investors own include Sorrento Therapeutics (SRNE), Allena Pharmaceuticals (ALNA), Tesla (TSLA), Meta Platforms (META), NIO (NIO), Viking Therapeutics (VKTX) and Energy Transfer (ET).

Company Calendar

Last Earnings
3/18/2025
Today
5/31/2025
Next Earnings (Estimated)
6/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:XCUR
Fax
N/A
Employees
50
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.91 million
Pretax Margin
-799.80%

Debt

Sales & Book Value

Annual Sales
$500,000.00
Price / Cash Flow
N/A
Book Value
$1.75 per share
Price / Book
5.58

Miscellaneous

Free Float
2,504,000
Market Cap
$61.73 million
Optionable
Not Optionable
Beta
3.86
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:XCUR) was last updated on 5/31/2025 by MarketBeat.com Staff
From Our Partners